<description>&lt;p&gt;Interview with Roni Shouval, MD, PhD, author of T-Cell Malignant Neoplasms After Chimeric Antigen Receptor T-Cell Therapy. Hosted by Vivek Subbiah, MD.&lt;br /&gt; &lt;br /&gt; &lt;strong&gt;Related Content:&lt;/strong&gt;&lt;/p&gt; &lt;ul&gt; &lt;li&gt;&lt;a class="related-article" href= "https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2024.0662?utm_source=podcast_platforms&amp;utm_medium=referral&amp;utm_campaign=related_article_links" target="_blank" rel="noopener"&gt;T-Cell Malignant Neoplasms After Chimeric Antigen Receptor T-Cell Therapy&lt;/a&gt;&lt;/li&gt; &lt;/ul&gt;</description>

JAMA Oncology Author Interviews

JAMA Network

T-Cell Malignant Neoplasms After Chimeric Antigen Receptor T-Cell Therapy

APR 18, 202419 MIN
JAMA Oncology Author Interviews

T-Cell Malignant Neoplasms After Chimeric Antigen Receptor T-Cell Therapy

APR 18, 202419 MIN

Description

Interview with Roni Shouval, MD, PhD, author of T-Cell Malignant Neoplasms After Chimeric Antigen Receptor T-Cell Therapy. Hosted by Vivek Subbiah, MD. Related Content: